824 related articles for article (PubMed ID: 17498878)
21. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A
Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis.
Xin XY; Ding JQ; Chen SD
J Alzheimers Dis; 2010; 19(4):1283-94. PubMed ID: 20061606
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer's disease susceptibility.
Yu JT; Tan L; Ou JR; Zhu JX; Liu K; Song JH; Sun YP
Brain Res; 2008 May; 1210():216-22. PubMed ID: 18423577
[TBL] [Abstract][Full Text] [Related]
24. Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease.
Fehér A; Juhász A; Rimanóczy A; Kálmán J; Janka Z
Alzheimer Dis Assoc Disord; 2009; 23(3):224-8. PubMed ID: 19812463
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
27. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
28. Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4.
Kim KW; Suh YJ; Park WY; Jhoo JH; Lee DY; Youn JC; Lee KH; Seo JS; Woo JI
Neurosci Lett; 2004 Aug; 366(2):182-6. PubMed ID: 15276243
[TBL] [Abstract][Full Text] [Related]
29. No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Koreans.
Kim KW; Jhoo JH; Lee KU; Lee DY; Lee JH; Youn JY; Lee BJ; Han SH; Woo JI
Am J Med Genet; 2000 Apr; 91(5):355-8. PubMed ID: 10766998
[TBL] [Abstract][Full Text] [Related]
30. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
[TBL] [Abstract][Full Text] [Related]
31. APOE epsilon4 is a high-risk factor for Alzheimer's disease in the Mongolian population.
Huriletemuer ; Wang B; Wang J; Wang G; Zhang C; Zhao S; Zhou S; Ma X; Wang de S
J Neurol Sci; 2010 Jan; 288(1-2):167-9. PubMed ID: 19819468
[TBL] [Abstract][Full Text] [Related]
32. Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease.
Mariani E; Seripa D; Ingegni T; Nocentini G; Mangialasche F; Ercolani S; Cherubini A; Metastasio A; Pilotto A; Senin U; Mecocci P
J Neurol Sci; 2006 Sep; 247(2):187-91. PubMed ID: 16784755
[TBL] [Abstract][Full Text] [Related]
33. APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.
Laws SM; Clarnette RM; Taddei K; Martins G; Paton A; Hallmayer J; Almeida OP; Groth DM; Gandy SE; Förstl H; Martins RN
Mol Psychiatry; 2002; 7(7):768-75. PubMed ID: 12192621
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
[TBL] [Abstract][Full Text] [Related]
35. Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women.
Corbo RM; Gambina G; Ulizzi L; Monini P; Broggio E; Rosano A; Scacchi R
Dement Geriatr Cogn Disord; 2007; 24(2):82-5. PubMed ID: 17565217
[TBL] [Abstract][Full Text] [Related]
36. Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer's disease.
Bi XH; Zhao HL; Zhang ZX; Zhang JW
Neurobiol Aging; 2009 Oct; 30(10):1601-7. PubMed ID: 18258338
[TBL] [Abstract][Full Text] [Related]
37. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
[TBL] [Abstract][Full Text] [Related]
38. [Study of relationship between ApoE epsilon4 allele and hippocampal atrophy in Alzheimer disease].
Li J; Kuang WH; Li J; Wang X; Huang MS; Wu DP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):50-2. PubMed ID: 15702779
[TBL] [Abstract][Full Text] [Related]
39. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
Bian JT; Zhang JW; Zhang ZX; Zhao HL
Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
[TBL] [Abstract][Full Text] [Related]
40. An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.
Lescai F; Chiamenti AM; Codemo A; Pirazzini C; D'Agostino G; Ruaro C; Ghidoni R; Benussi L; Galimberti D; Esposito F; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Sorbi S; Tagliavini F; Albani D; Martinelli Boneschi F; Binetti G; Santoro A; Forloni G; Scarpini E; Crepaldi G; Gabelli C; Franceschi C
J Alzheimers Dis; 2011; 24(2):235-45. PubMed ID: 21263195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
